Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Lilly weight-loss drug copycats dealt blow
What end of Eli Lilly's weight-loss drug shortage means for the competition
The FDA confirmed Thursday that Eli Lilly has increased production of its blockbuster weight-loss drug Zepbound and type 2 diabetes drug Mounjaro, implying the company can now supply enough doses to meet current demand.
Hims & Hers Health stock tanks after FDA says competitor Eli Lilly’s weight-loss drug shortage is over
The San Francisco telehealth company had capitalized on the shortage by making copycat versions of popular brand-name GLP-1 medications.
Eli Lilly’s Weight-Loss, Diabetes Drug Shortages Are Over, FDA Says
The removal of Zepbound and Mounjaro from the regulator’s shortage list could lead to restrictions on pharmacies making custom-made versions.
FDA, Exact Sciences and Cologuard
Exact Sciences' upgraded Cologuard test gets FDA approval
The U.S. Food and Drug Administration has approved Cologuard Plus, the new version of Exact Sciences’ stool test for colon cancer that is shown to find more cancers and have fewer false positives than the company's earlier version.
FDA Approves Exact Sciences' Colorectal Cancer Screening Test Cologuard Plus
Exact Sciences Corp. (EXAS), a provider of cancer screening and diagnostic tests, Friday said the U.S. Food and Drug Administration
Exact Sciences wins FDA approval for improved stool-based colon cancer test
Exact Sciences won approval on Friday for an improved version of a stool-based screening test for colon cancer
4h
on MSN
Exclusive-Thermo Fisher's plant making infant RSV drug breached FDA rules, documents show
By Patrick Wingrove (Reuters) -One of the largest contract drug manufacturing plants in the U.S. owned by Thermo Fisher ...
ncbiotech.org
29m
Atsena lands another FDA incentive for gene therapy to fight blindness
Atsena Therapeutics, a Durham company developing gene therapies to treat genetic causes of blindness, has received another ...
inforum
19h
FDA approves the first new schizophrenia drug in over 30 years
FARGO — A new FDA approved drug, to help people with schizophrenia, will soon be accessible for medical officials to ...
JD Supra
2h
EPA, FDA, and USDA Release Tool to Help Companies Developing Microbial Biotechnology Products Navigate Regulatory Landscape
On October 2, 2024, the U.S. Environmental Protection Agency (EPA), U.S. Food and Drug Administration (FDA), and U.S.
ENDPOINTS NEWS
1d
FDA's drug center launches new coordinating body for modeling and simulation
The FDA's Center for Drug Evaluation and Research on Wednesday officially launched a new center of excellence to better ...
Monthly Prescribing Reference
2h
FDA Clears Cologuard Plus for Colorectal Cancer Screening
The approval was based on data from the BLUE-C trial, which assessed the sensitivity and specificity of the Cologuard Plus test vs FIT in asymptomatic adults scheduled for screening colonoscopy.
4h
on MSN
Summit Therapeutics Stock Jumps as Lung Cancer Drug Placed on FDA Fast Track
Key Takeaways Summit Therapeutics stock jumped Friday morning, a day after the company said its developmental lung cancer ...
19h
FDA recalls chocolate cone treat sold in Kansas
A Colorado-based candy shop issued a recall after discovering one of its products caused an allergic reaction. The Food and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Eli Lilly
Mounjaro
Feedback